×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
TCRX – tscan therapeutics, inc. (US:NYSE)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
TCRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/15
08:04 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Medium
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
11/14
05:32 am
tcrx
TScan Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
Medium
Report
TScan Therapeutics Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag [Yahoo! Finance]
11/12
12:36 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
11/12
09:49 am
tcrx
TScan Therapeutics GAAP EPS of -$0.25, revenue of $1.04M Nov. 12, 2024 9:48 AM ET By: Urvi Shah , SA News Editor [Seeking Alpha]
Medium
Report
TScan Therapeutics GAAP EPS of -$0.25, revenue of $1.04M Nov. 12, 2024 9:48 AM ET By: Urvi Shah , SA News Editor [Seeking Alpha]
11/12
07:00 am
tcrx
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Medium
Report
TScan Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate Update
11/7
06:39 am
tcrx
TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock? [Yahoo! Finance]
Medium
Report
TScan Therapeutics (TCRX) Soars 7.6%: Is Further Upside Left in the Stock? [Yahoo! Finance]
11/6
08:07 am
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
Medium
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "buy" rating re-affirmed by analysts at Needham & Company LLC. They now have a $11.00 price target on the stock.
11/5
06:24 pm
tcrx
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Low
Report
TScan Therapeutics, Inc. (NASDAQ: TCRX) had its "outperform" rating re-affirmed by analysts at Wedbush. They now have a $10.00 price target on the stock.
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
11/21
08:06 am
tcrx
Form 8-K TScan Therapeutics, Inc. For: Nov 15
Medium
Report
Form 8-K TScan Therapeutics, Inc. For: Nov 15
11/19
04:27 pm
tcrx
Form 4 TScan Therapeutics, Inc. For: Nov 15 Filed by: Nichols Weston
Medium
Report
Form 4 TScan Therapeutics, Inc. For: Nov 15 Filed by: Nichols Weston
11/14
04:40 pm
tcrx
Form SC 13G/A TScan Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
Medium
Report
Form SC 13G/A TScan Therapeutics, Inc. Filed by: BIOTECHNOLOGY VALUE FUND L P
11/14
04:07 pm
tcrx
Form SC 13G/A TScan Therapeutics, Inc. Filed by: K2 HealthVentures Equity Trust LLC
Medium
Report
Form SC 13G/A TScan Therapeutics, Inc. Filed by: K2 HealthVentures Equity Trust LLC
11/14
03:06 pm
tcrx
Form SC 13G/A TScan Therapeutics, Inc. Filed by: Cormorant Asset Management, LP
Low
Report
Form SC 13G/A TScan Therapeutics, Inc. Filed by: Cormorant Asset Management, LP
11/12
09:34 am
tcrx
Form 10-Q TScan Therapeutics, Inc. For: Sep 30
Medium
Report
Form 10-Q TScan Therapeutics, Inc. For: Sep 30
11/12
09:33 am
tcrx
Form 8-K TScan Therapeutics, Inc. For: Nov 12
Medium
Report
Form 8-K TScan Therapeutics, Inc. For: Nov 12
11/8
02:21 pm
tcrx
Form SC 13G TScan Therapeutics, Inc. Filed by: BlackRock, Inc.
Low
Report
Form SC 13G TScan Therapeutics, Inc. Filed by: BlackRock, Inc.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: